Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Maravai LifeSciences
MRVI
$969M
| $1.53M | ﹤0.01% |
184,189
+143,184
| +349% | +$1.24M |
|
3002
Methode Electronics
MEI
$496M
| $1.53M | ﹤0.01% |
127,917
+67,656
| +112% | +$755K |
|
3003
Blend Labs
BLND
$431M
| $1.53M | ﹤0.01% |
407,774
+295,460
| +263% | +$979K |
|
3004
Universal Insurance Holdings
UVE
$1.22B
| $1.53M | ﹤0.01% |
68,969
+28,278
| +69% | +$571K |
|
3005
American Express Global Business Travel
GBTG
$4.93B
| $1.53M | ﹤0.01% |
198,673
+155,696
| +362% | +$1.08M |
|
|
HUT
3006
Hut 8
HUT
$12.1B
| $1.53M | ﹤0.01% |
124,527
+31,632
| +34% | +$421K |
|
|
XRN
3007
Chiron Real Estate Inc
XRN
$514M
| $1.53M | ﹤0.01% |
30,810
+14,341
| +87% | +$676K |
|
3008
Perspective Therapeutics
CATX
$332M
| $1.52M | ﹤0.01% |
114,075
+97,493
| +588% | +$1.3M |
|
3009
National Vision
EYE
$1.77B
| $1.52M | ﹤0.01% |
139,302
+10,373
| +8% | +$121K |
|
3010
Evolus
EOLS
$385M
| $1.52M | ﹤0.01% |
93,662
+68,213
| +268% | +$953K |
|
3011
NB Bancorp
NBBK
$1.01B
| $1.51M | ﹤0.01% |
81,114
+34,235
| +73% | +$605K |
|
3012
Brighthouse Financial
BHF
$3.56B
| $1.51M | ﹤0.01% |
33,429
-33,503
| -50% | -$1.51M |
|
3013
ProShares UltraPro Short QQQ
SQQQ
$2B
| $1.5M | ﹤0.01% |
8,136
+4,980
| +158% | +$1.05M |
|
3014
iShares ESG Aware MSCI USA ETF
ESGU
$17.9B
| $1.5M | ﹤0.01% |
11,899
-3,700
| -24% | -$449K |
|
|
AMED
3015
DELISTED
Amedisys
AMED
| $1.5M | ﹤0.01% |
15,529
+5,142
| +50% | +$502K |
|
3016
Alpha and Omega Semiconductor
AOSL
$950M
| $1.5M | ﹤0.01% |
40,359
+31,725
| +367% | +$1.2M |
|
3017
Tompkins Financial
TMP
$1.43B
| $1.5M | ﹤0.01% |
25,878
+13,878
| +116% | +$792K |
|
3018
Douglas Dynamics
PLOW
$1.02B
| $1.49M | ﹤0.01% |
54,116
+30,795
| +132% | +$812K |
|
3019
FTAI Infrastructure
FIP
$441M
| $1.49M | ﹤0.01% |
159,387
+117,863
| +284% | +$1.09M |
|
3020
Castle Biosciences
CSTL
$855M
| $1.49M | ﹤0.01% |
52,301
+39,567
| +311% | +$1.01M |
|
3021
CALL
American Express
AXP
$227B
| $1.49M | ﹤0.01% |
5,500
-23,900
| -81% | -$5.95M |
|
3022
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
| $1.49M | ﹤0.01% |
18,760
| – | – |
|
3023
PUT
Cummins
CMI
$87.5B
| $1.49M | ﹤0.01% |
+4,600
| New | +$1.36M |
|
3024
Choice Hotels
CHH
$5.07B
| $1.49M | ﹤0.01% |
11,409
-19,055
| -63% | -$2.39M |
|
3025
PUT
Otis Worldwide
OTIS
$27.4B
| $1.49M | ﹤0.01% |
+14,300
| New | +$1.36M |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.